Cargando…
Docking and quantitative structure–activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors
PDE3s belong to the phosphodiesterases family, where the PDE3A isoform is the major subtype in platelets involved in the cAMP regulation pathway of platelet aggregation. PDE3A inhibitors have been designed as potential antiplatelet agents. In this work, a homology model of PDE3A was developed and us...
Autores principales: | Muñoz-Gutiérrez, Camila, Cáceres-Rojas, Daniela, Adasme-Carreño, Francisco, Palomo, Iván, Fuentes, Eduardo, Caballero, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720733/ https://www.ncbi.nlm.nih.gov/pubmed/29216268 http://dx.doi.org/10.1371/journal.pone.0189213 |
Ejemplares similares
-
Calcium/Calpain mediated regulation of cyclic nucleotide phosphodiesterases, PDE3A and PDE5, in human platelets
por: Rybalkina, Irina G, et al.
Publicado: (2011) -
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
por: Omar, Faisa, et al.
Publicado: (2019) -
Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue
por: Ahmad, Faiyaz, et al.
Publicado: (2016) -
Ribosome-mediated biosynthesis of pyridazinone oligomers in vitro
por: Lee, Joongoo, et al.
Publicado: (2022) -
Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
por: Organtzis, John, et al.
Publicado: (2014)